Cargando…
La metformine est associée à une moindre mortalité chez les patients diabétiques hospitalisés pour la COVID-19
Metformin exerts anti-inflammatory and immunosuppressive effects. We addressed the impact of prior metformin use on the prognosis of patients with type 2 diabetes hospitalised for COVID-19. We used data from the nationwide observational CORONADO cohort that included patients with diabetes hospitalis...
Autores principales: | Lalau, Jean-Daniel, Al-Salameh, Abdallah, Wiernsperger, Nicolas, Goronflot, Thomas, Pichelin, Matthieu, Wargny, Matthieu, Desailloud, Rachel, Hadjad, Samy, Gourdy, Pierre, Cariou, Bertrand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904517/ http://dx.doi.org/10.1016/j.mmm.2021.02.013 |
Ejemplares similares
-
Comment on Chen et al. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication. Diabetes Care 2020;43:1399–1407
por: Cariou, Bertrand, et al.
Publicado: (2020) -
Diabète et COVID-19 : les leçons de CORONADO
por: Cariou, Bertrand, et al.
Publicado: (2021) -
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study
por: Cariou, Bertrand, et al.
Publicado: (2021) -
Vieillissement de la population, dématérialisation, une nouvelle donne pour la pharmacie
por: Zambrowski, Jean-Jacques
Publicado: (2022) -
Les soignants et les familles confrontés à la mort due à la Covid-19
por: Faure, Nadine
Publicado: (2022)